Access

Correspondence


Nature Medicine 14, 1009 - 1010 (2008)
doi:10.1038/nm1008-1009b

Reply to "SNO-hemoglobin and hypoxic vasodilation"

Rakesh Patel1 & Tim Townes2

  1. Department of Pathology, 720 20th Street South, Birmingham, Alabama 35294, USA.
    e-mail: ttownes@uab.edu
  2. Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Schools of Medicine and Dentistry, 720 20th Street South, Birmingham, Alabama 35294, USA.
    e-mail: rakeshp@uab.edu

In response to our recent paper1, Stamler et al. state that "an extensive body of evidence from our own and other laboratories supports a major role for SNO-Hb [S-nitrosohemoglobin] (in which a nitric oxide (NO) group is covalently coupled to Cys93 within the beta-chain [betaCys93]) in the physiological response of hypoxic vasodilation..." However, we demonstrated that mutation of betaCys93 to alanine has a surprisingly minor phenotype in our humanized mouse model. We state in our paper, "betaCys93 is not essential for normal development or physiology under basal or exercise-stress conditions, that the absence of SNO-Hb does not result in pulmonary hypertension under normal conditions and that SNO-Hb is not required for RBCs to stimulate hypoxic vasodilation ex vivo.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Hemoglobin as a chariot for NO bioactivity

Nature Medicine News and Views (01 Jul 2002)

NO, SNO and low O 2

Nature Medicine News and Views (01 Oct 2001)

$rb.Type.Code